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In the Consensus Report, the Committee recommended that the Secretary of HHS ("Secretary") define the EHB Package to reflect the scope and design of health benefits offered by small employers. 18 The Committee also identified criteria for the content of the aggregate EHB Package and specific components of the EHB Package, 19 as well as four policy foundations that should guide the Secretary in determining the EHB Package, including economics, ethics, population-based health, and evidence-based practice. 20 Finally, the Committee made five specific sets of recommendations. The Committee first recommended that the Secretary establish a specific EHB Package benchmarked to a typical small employer plan, modified as necessary to reflect the ten ACA-required benefit categories, and guided by a national average premium target. 21 The Committee's second through fifth recommendations related to establishing a framework for obtaining and analyzing data necessary for monitoring and implementing the EHB Package, promoting state innovation, updating the EHB Package, and creating a National Benefits Advisory Council (NBAC). 22 Following the release of the Consensus Report, HHS held an additional series of "listening sessions" with consumers, providers, employers, plans, state representatives, and other stakeholders in different cities across the United States. 23 On December 16, 2011, HHS released its Essential Health Benefits Bulletin ("EHB Bulletin"). 24 The EHB Bulletin provides information and solicits comments on a regulatory approach that HHS plans to propose to define the EHB Package. 25 In the EHB Bulletin, HHS explains its intent not to propose one comprehensive, specific benefit package for all health plans in the nation to follow. 26 Instead, HHS intends to leave the states broad discretion in defining the EHB Package by allowing each state to select a benchmark plan in that state. 27 The selected benchmark plan would serve as a reference plan, reflecting both the scope of services and any limits offered by a typical employer plan in that state. 28 HHS intends to allow health plans to make adjustments to the benchmarked benefits (including adjustments to the specific services covered and to any quantitative limits provided) and is considering allowing health plans to substitute services both within and across the ten ACA-required benefit categories. 29 This Article analyzes the initial steps taken by HHS to implement the EHB Provision, 30 with a focus on the essential mental health and substance use disorder
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sub-provision codified at section 1302(b)(1)(E) of ACA (the "Mental Health Benefit Sub-Provision"). 31 Thus far, HHS understandably has focused on the ten ACArequired benefit categories as a whole and not just the Mental Health Benefit SubProvision. 32 In its Workshop Report, the Committee explained that "time constraints prohibited the [C]ommittee from hearing testimony related to each of the[] [ten ACA-required] categories in detail." 33 The scant attention received by mental health and substance use disorder benefits from HHS likely is a result of the time constraints faced by the Committee. Notwithstanding, the result is a tentative HHS plan that is timid with respect to the comprehensiveness and specificity of all benefits, including mental and substance use disorder benefits. This Article urges HHS to consider the possibility of long-term total healthcare cost returns on initial comprehensive mental health treatment investments. This Article also seeks to remedy the informational and research limitations in HHS's initial implementation of the EHB Provision.
This Article proceeds as follows: Part II examines the historically inferior public and private health insurance benefits available to individuals with illnesses traditionally classified as mental. Part III reviews the development, application, and limitations of relevant federal mental health insurance laws, recommendations, and proposals, including the Mental Health Parity Act of 1996, the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008, the Affordable Care Act of 2010, the Workshop Report issued on August 29, 2011, the Consensus Report issued on October 7, 2011, and the EHB Bulletin issued on December 16, 2011. Part IV examines the current health plan cost literature that supports mental health parity and comprehensive mental health and substance use disorder benefits. Part IV also justifies and proposes the adoption of a comprehensive and specific essential mental health and substance use disorder services benefit.
II. HISTORICALLY INFERIOR INSURANCE BENEFITS FOR INDIVIDUALS WITH MENTAL ILLNESS 34

A. INFERIOR PUBLIC HEALTH PROGRAM BENEFITS
Public healthcare programs and private health insurers have long provided less comprehensive insurance benefits to individuals with mental illness in both the inpatient 35 and outpatient 36 settings. 37 The Medicare program, a public healthcare 31 Id. § 1302(b)(1)(E). 32 See infra notes 153, 228-32 and accompanying text. 33 WORKSHOP REPORT, supra note 10, at 71. 34 Part II of this Article is reprinted with updates and minor changes with permission from Tovino, supra note 2, at pt. 1. 35 An inpatient may be defined as a patient who: (1) receives room, board, and professional services in a medical institution for a twenty-four-hour period or longer; or (2) is expected by the institution to receive room, board, and professional services in the institution for a twenty-four-hour period or longer even though it later develops that the patient dies, is discharged, or is transferred to another facility and does not actually stay in the institution for twenty-four hours. See 42 C.F.R. § 440.2(a) (2010) . 36 An outpatient may be defined as a patient of an organized medical facility, or distinct part of that facility, who is expected by the facility to receive and who does receive professional services for less than a twenty-four-hour period regardless of the hour of admission, whether a bed is used, and whether the patient remains in the facility past midnight. See id.
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program funded and administered by the U.S. government, provides health insurance for individuals who are sixty-five years of age or older, individuals under the age of sixty-five who have certain disabilities, and individuals with end-stage renal disease regardless of age.
38 Both Medicare Part A, which provides hospital insurance benefits, 39 and Medicare Part B, which provides physician and other supplementary medical insurance benefits, 40 provide less comprehensive insurance benefits for beneficiaries with mental illness.
Medicare Part A restricts beneficiaries to a lifetime maximum of 190 inpatient days in a free-standing psychiatric hospital but places no lifetime maximum on the number of days a beneficiary may stay as an inpatient in a non-psychiatric hospital. 41 The federal government justifies the 190-day limitation as a cost-control measure. 42 Some Medicare beneficiaries with severe chronic mental illnesses, including chronic schizophrenia and affective disorders, would easily exceed 190 inpatient days over their lifetime without the limitation. 43 With the limitation, affected beneficiaries are limited to: (1) Medicare-covered outpatient mental healthcare, which may be insufficiently intense to treat an acute illness episode and may result in suicide or other poor outcomes; (2) Medicare-covered inpatient care provided in a nonpsychiatric setting by clinicians who may lack the education, training, and experience necessary to treat complex psychiatric conditions; or (3) non-covered inpatient care provided in a psychiatric setting for which the beneficiary must pay entirely out of pocket. 44 Some beneficiaries who consider unsatisfactory the options 37 
See, e.g., SUBSTANCE ABUSE & MENTAL HEALTH SERVS. ADMIN., DEP'T HEALTH & HUMAN SERVS., MENTAL HEALTH: A REPORT OF THE SURGEON GENERAL 418 (1999) [hereinafter SURGEON
GENERAL REPORT] ("Private health insurance is generally more restrictive in coverage of mental illness than in coverage for somatic illness."). . 42 See Judith R. Lave & Howard H. Goldman, Medicare Financing for Mental Health Care, 9 HEALTH AFF. 19, 21 (1990) ("This limit assures that Medicare will not pay for the long-term custodial support of the mentally ill."); NAT'L POLICY FORUM, supra note 41, at 10 (explaining that Medicare Part A's 190-day lifetime maximum on mental healthcare provided in a free-standing psychiatric hospital was intended to limit the federal government's mental healthcare costs). 43 See, e.g., Letter from Michael J. Fitzpatrick, Exec. Dir., Nat'l Alliance on Mental Illness, to Rep. Paul Tonko (Sept. 20, 2010), available at http://www.nami.org/Template.cfm?Section= Issue_Spotlights&template=/ContentManagement/ContentDisplay.cfm&ContentID=107512 (explaining that many non-elderly Medicare beneficiaries with disabilities have already exceeded the 190-day limit or are at imminent risk of doing so). 44 CBO MEMORANDUM, supra note 41, at 13 (noting that once a Medicare beneficiary reaches the 190-day limitation, the beneficiary may turn for care to a general hospital (where the limit does not apply) or to outpatient care, or may forgo psychiatric care entirely); id. at 10 (" [T] he alternative provider might be less capable of providing the most appropriate care if psychiatric hospitals have specialized in treating certain kinds of patients-for example, those who need acute care for severe or complex conditions."); CAL. HEALTH ADVOCATES, SUMMARY OF MEDICARE BENEFITS AND COST A PROPOSAL FOR COMPREHENSIVE AND SPECIFIC ESSENTIAL MENTAL HEALTH AND SUBSTANCE USE DISORDER BENEFITS 477 of outpatient mental healthcare or inpatient care in a non-psychiatric setting may forgo mental healthcare entirely if they are unable to pay 100 percent of the costs of inpatient care provided in a psychiatric setting.
45
In addition to the Medicare Part A limitation on inpatient care provided in a free-standing psychiatric hospital, Medicare Part B also provides less comprehensive outpatient mental health benefits than non-mental health benefits. 46 In particular, Medicare Part B currently imposes a forty percent beneficiary co-insurance 47 on most outpatient mental health services, including individual, family, and group psychotherapy services, instead of the twenty percent beneficiary co-insurance traditionally applied to non-mental health outpatient services. 48 Although Medicare will phase out the disparate co-insurances by the year 2014, Medicare beneficiaries who receive outpatient mental health services between the present and 2014 will be required to pay more out of pocket for outpatient mental health services compared to outpatient physical health services. 49 The Medicaid Program, a public healthcare program jointly funded by the federal and state governments and administered by the states, provides healthcare to certain low-income individuals and families who fit into an eligibility group recognized by federal and state law. 50 Like the Medicare Program, the Medicaid Program also has limited support for individuals who require mental healthcare in certain inpatient psychiatric settings. For example, Medicaid does not cover inpatient mental healthcare provided to individuals age twenty-two through sixty-four in an SHARING FOR 2011 , available at http://www.cahealthadvocates.org/basics/benefitssummary.html (explaining that Medicare beneficiaries pay out of pocket for 100% of the costs of inpatient services provided in a psychiatric setting after 190 days). 45 CBO MEMORANDUM, supra note 41, at 13 ("[E]nrollees who consider alternative sources of covered care to be unsatisfactory substitutes may forgo care entirely, either because they are unable to pay for psychiatric hospital care themselves or because they choose not to do so."). 46 47 Although no health insurance-related federal statute or regulation defines "co-insurance," it may be defined as the insured's liability after the insurer has paid its portion of the total healthcare costs. See id. at 2, 6 n.ix (defining co-insurance without reference to a statute or regulation and with respect to common parlance; that is, the beneficiary's liability after Medicare payment is made). 48 See 42 U.S.C. § 1395l(c) (2006 & Supp. IV 2010) (calculating as Medicare-incurred expenses only 62.5% of the outpatient expenses associated with the treatment of mental, psychoneurotic, and personality disorders). Until 2010, Medicare was thus responsible for only 50% (i.e., 62.5% x 80% (80% is the Medicare approved amount)) of the cost of most outpatient mental health services, and the Medicare beneficiary was responsible for the remaining 50%. In 2008, President George W. Bush signed into law the Medicare Improvements for Patients and Providers Act of 2008, section 102 of which increased Medicare's portion of incurred expenses for outpatient mental health services to 68.75% in 2010 and 2011 (resulting in a 45% beneficiary co-insurance in those years), 75% in 2012 (resulting in a 40% beneficiary co-insurance), 81.25% in 2013 (resulting in a 35% beneficiary coinsurance), and 100% in 2014 and thereafter (resulting in a 20% co-insurance). By 2014, Medicare thus will pay 80% of (and Medicare beneficiaries will pay a 20% co-insurance on) all outpatient mental health services. 51 defined as a hospital, nursing facility, or other institution of more than sixteen beds that is primarily engaged in providing diagnosis, treatment, or care of persons with mental disease. 52 Medicaid also does not cover mental healthcare provided in small residential facilities, including halfway houses, adult residential foster homes, and crisis centers. 53 Due to these limitations, many Medicaid beneficiaries are limited to: (1) Medicaid-covered outpatient mental healthcare, which may be insufficiently intense to treat an acute illness episode and may result in suicide or other poor outcomes; (2) Medicaidcovered inpatient care provided in a facility other than an IMD or a small residential facility by clinicians who may lack the education, training, and experience necessary to treat complex psychiatric conditions; or (3) non-covered inpatient care provided in an IMD or small residential facility for which the beneficiary must pay entirely out of pocket. 54 Because Medicaid eligibility generally requires evidence of low income, 55 most Medicaid beneficiaries will not be able to pay 100% of the cost of treatment in an IMD or small residential facility. 62 Before President Obama signed ACA into law and unless otherwise prohibited by state law, private health insurers were permitted to sell individual policies and group health plans that contained benefits for illnesses traditionally classified as physical, such as cancer and pregnancy, but that did not contain benefits for illnesses traditionally classified as mental, including major depression and bipolar disorder. 63 Under ACA, mental health and substance use disorder benefits must be part of the EHB Package offered in the exchange-offered qualified health plan setting, 64 the non-exchange individual health plan setting, the non-exchange small group health plan setting, the Medicaid benchmark and benchmark-equivalent plan setting, and the state basic health plan setting. 65 However, as discussed in more detail in Part III.C, infra, the EHB Package is not required to be provided by grandfathered health plans, large group health plans (at least until 2017, when ACA permits the exchanges to open to large employers), self-insured group health plans, or traditional Medicaid. 66 Even after the full implementation of healthcare reform, then, millions of insureds still will not have a federal legal right to a mandatory mental health and substance use disorder benefit. 67 Prior to ACA, some health plans voluntarily included insurance benefits for mental illness; however, many of these plans imposed higher cost-sharing requirements and greater administrative restrictions on mental health coverage, including higher deductibles, co-payments, and co-insurance amounts for mental healthcare, as well as lower inpatient day and outpatient visit limitations and annual and lifetime spending caps for mental healthcare. 68 Although MHPAEA requires parity between physical health benefits and mental health benefits in terms of deductibles, co-payments, co-insurance, inpatient day limitations, and outpatient visit limitations, 69 as discussed below in Part III.B, MHPAEA initially regulated only large group health plans, not small group health plans. 70 As enacted, MHPAEA also did not apply to individual health insurance policies sold in the private market, the Medicare Program, Medicaid non-managed care plans, or any self-funded nonfederal governmental group plan whose sponsor has opted out of MHPAEA.
71
Before ACA and unless otherwise prohibited by state law, many public healthcare programs and private health plans thus were permitted to contain disparate mental health benefits. 72 Although ACA broadened the application of MHPA, as expanded by MHPAEA, from just the large group health plan setting to the exchange-offered qualified health plan setting and the Medicaid benchmark and benchmark-equivalent plan setting, 73 some non-exchange plans continue to be exempt from MHPA as expanded by MHPAEA and ACA (collectively, "federal mental health parity law"). The Medicare Program and traditional fee-for-service Medicaid also continue to be exempt from federal mental health parity law, as are self-funded, non-federal governmental plans whose sponsors have opted out of federal mental health parity law. 74 Even after the full implementation of healthcare reform, then, many public healthcare program beneficiaries and some individuals with private health insurance still will not have a federal legal right to equal physical health and mental health insurance benefits. 72 Some states do require small group health plans and individual health insurance policies to establish parity between physical and mental health benefits in terms of deductibles, co-payments, coinsurance, inpatient day limitations, and outpatient visit limitations. See, e.g., 24 ME. REV. STAT. tit. 24, § 2325-A(5-C)(B)(1) (2010) (requiring health insurance policies issued in Maine to provide insurance benefits for the diagnosis and treatment of mental illness under terms and conditions that are no less extensive than the benefits provided for treatment of physical illness); id. § 2325-A(5-C)(B)(4) (prohibiting health insurance policies issued in Maine from containing separate maximums for physical and mental illness, separate deductibles and co-insurance amounts for physical illness and mental illness, separate out-of-pocket limits for physical illness and mental illness, or separate office visit limits for physical illness and mental illness); MD. CODE ANN., INS. § 15-802(c) (West 2012) (requiring individual and group health insurance policies issued in Maryland to provide benefits for the diagnosis and treatment of mental illness under the same terms and conditions that apply under the policy or contract for the diagnosis and treatment of physical illness). 73 In an attempt to remedy some of the historically inferior health insurance benefits available to individuals with mental illness, the federal government took its first step towards establishing mental health parity on September 26, 1996, when President Bill Clinton signed the Federal Mental Health Parity Act into law. 77 In terms of application, MHPA was very limited. As originally enacted, the statute only regulated insured and self-insured group health plans of large employers, defined as those employers that employ an average of fifty-one or more employees.
78 MHPA thus did not apply to the group health plans of small employers. 79 MHPA also did not apply to individual health plans, the Medicare Program, Medicaid non-managed care plans, or any self-funded, non-federal governmental plan whose sponsor opted out of MHPA. 80 Finally, MHPA contained an "increased cost" exemption for covered group health plans or health insurance coverage offered in connection with such plans if the application of MHPA resulted in an increase in the cost under the 76 1996) . 78 See id. § 712(a)(1), (2) (applying in each case to "a group health plan (or health insurance coverage offered in connection with such a plan . . . )"). 79 See id. § 712(c)(1)(A)-(B) (exempting from MHPA application group health plans of small employers; defining small employers as those who employed an average of at least two but not more than fifty employees on business days during the preceding calendar year and who employs at least two employees on the first day of the plan year). 80 In terms of its substantive provisions, MHPA was neither a mandated offer nor a mandated benefit law; that is, nothing in MHPA required a covered large group health plan to actually offer or provide any mental health benefits. 83 As originally enacted, MHPA also was not a comprehensive parity law because it neither protected individuals with substance use disorders 84 nor required parity between physical and mental health benefits in terms of deductibles, co-payments, coinsurance, inpatient day limitations, or outpatient visit limitations. 85 As originally enacted, what MHPA did do was regulate lifetime and annual spending limits that covered group health plans applied to mental health benefits if such plans already offered both physical and mental health benefits. 86 More specifically, if a covered group health plan did not impose an aggregate lifetime or annual limit on substantially all physical health benefits, the plan was prohibited from imposing an aggregate lifetime or annual limit on offered mental health benefits. 87 If a covered group health plan did impose an aggregate lifetime or annual limit on substantially all physical health benefits, the plan was required to apply the applicable limit to both physical health and mental health benefits and not distinguish in the application of such limit between the two benefit sets; or, the plan was prohibited from imposing any aggregate lifetime or annual limit on mental health benefits that was less than the applicable lifetime or annual limit imposed on physical health benefits.
88 MHPA (and, as discussed in Part III.C, infra, ACA) thus would prohibit a covered group health plan from imposing a $20,000 annual cap or a $100,000 lifetime cap on mental healthcare if the plan had no annual or lifetime caps for physical healthcare or if the plan had higher caps, such as a $50,000 annual cap or a $500,000 lifetime cap, for physical healthcare. 83 See MHPA § 712(b)(1) ("Nothing in this section shall be construed as requiring a group health plan (or health insurance coverage offered in connection with such a plan) to provide any mental health benefits . . . . "). 84 See id. § 712(e)(4) ("The term 'mental health benefits' means benefits with respect to mental health services, as defined under the terms of the plan or coverage (as the case may be), but does not include benefits with respect to treatment of substance abuse or chemical dependency."). 85 See id. § 712(b)(2) ("Nothing in this Section shall be construed . . . as affecting the terms and conditions (including cost sharing, limits on numbers of visits or days of coverage, and requirements relating to medical necessity) relating to the amount, duration, or scope of mental health benefits under the plan or coverage . . . ."). 86 See id. § 712(a)(1)-(2). 87 See id. § 712(a)(1)(A) (no aggregate lifetime limits); id. § 712(a)(2)(A) (no annual limits). 88 See id. § 712(a)(1)(B) (aggregate lifetime limits); id. § 712(a)(2)(B) (annual limits). 89 enacted, MHPAEA (like MHPA) only regulated insured and self-insured group health plans of large employers, defined as those employers that employ an average of fifty-one or more employees.
90 MHPAEA (like MHPA) thus did not apply to small group health plans, individual health plans, the Medicare Program, Medicaid non-managed care plans, or any self-funded, non-federal governmental plans whose sponsor opted out of MHPAEA. 91 In terms of its substantive provisions, MHPAEA also was neither a mandated offer nor a mandated benefit law; that is, nothing in MHPAEA required a covered group health plan to actually offer or provide any mental health benefits. 92 Like MHPA, MHPAEA also contained an "increased cost" exemption for covered group health plans and health insurance coverage offered in connection with such plans, but under MHPAEA the amount of the required cost increase increased, at least for the first year. 93 That is, a covered plan that could demonstrate a cost increase of at least two percent in the first plan year and one percent in each subsequent plan year of the actual total costs of coverage with respect to medical and surgical benefits and mental health and substance use disorder benefits would be eligible for an exemption from MHPAEA for such year.
94
MHPAEA required determinations of exemption-qualifying cost increases to be made and certified in writing by a qualified and licensed actuary who in good standing belongs to the American Academy of Actuaries.
95
Notwithstanding these limitations and exemptions, MHPAEA built on MHPA by protecting individuals with substance use disorders 96 and by imposing comprehensive parity requirements on covered group health plans. In particular, MHPAEA required financial requirements (including deductibles, co-payments, coinsurance, and other out-of-pocket expenses) 97 and treatment limitations (including inpatient day and outpatient visit limitations) 98 that covered group health plans imposed on mental health and substance use disorder benefits to be no more restrictive than the predominant financial requirements and treatment limitations imposed on substantially all physical health benefits. 99 MHPAEA thus prohibited covered group health plans from imposing higher deductibles, co-payments, or co- 90 Id. § 512(a)(1) (applying only to group health plans or health insurance coverage offered in connection with such plans). 91 See supra note 80. 92 See MHPAEA § 512(a)(1) (regulating only those group health plans that offer both physical health and mental health benefits); The Mental Health Parity and Addiction Equity Act, supra note 80 (stating, "MHPAEA does not require large group health plans and their health insurance issuers to cover MH/SUD [mental health and substance use disorder] benefits. The law's requirements apply only to large group health plans and their health insurance issuers that choose to include MH/SUD benefits in their benefit packages."). 93 See MHPAEA § 512(a)(3) (establishing new cost exemption provisions). 94 Id. 95 Id. 96 See id. § 512(a)(4) (adding a new definition of "substance use disorder benefits"); id. § 512(a)(1) (regulating the financial requirements and treatment limitations that are applied to both mental health and substance use disorder benefits). 97 See id. § 512(a)(1) (including within the definition of "financial requirements" deductibles, copayments, co-insurance, and out-of-pocket expenses). 98 See id. (including within the definition of "treatment limitations" limits on the frequency of treatment, number of visits, days of coverage, and other similar limits on the scope or duration of treatment). 99 See id. (requiring both financial requirements and treatment limitations applicable to mental health and substance use disorder benefits to be no more restrictive than the predominant financial requirements and treatment limitations applied to substantially all physical health benefits covered by the plan).
insurances, or lower inpatient day and outpatient visit maximums, on individuals who were seeking care for conditions-such as bipolar disorder, schizophrenia, alcohol abuse, and drug abuse-compared to individuals who were seeking care for traditional physical conditions-such as pregnancy, cancer, and orthopedic injuries. On February 2, 2010, the Departments of Treasury, Labor, and HHS co-released an interim final rule implementing MHPAEA's requirements. 100 The interim final rule clarified in favor of patients with mental health conditions several questions that MHPA and MHPAEA had left open, including the question whether a covered group health plan could impose separately accumulating financial requirements or quantitative treatment limitations on mental health and substance use disorder benefits ("No"), 101 and the question whether a covered group health plan could impose a non-quantitative treatment limitation (including a medical necessity limitation or an experimental/investigative limitation) on mental health and substance use disorder benefits (also "No").
C. THE AFFORDABLE CARE ACT OF 2010
Before healthcare reform, mental health insurance benefits thus were regulated by MHPA as expanded by MHPAEA as well as by more stringent state law. 103 In March 2010, President Obama further expanded mental health parity and mental health and substance use disorder benefit law by signing ACA into law.
104 Best known for its controversial (and constitutionally challenged) individual health insurance mandate, 105 ACA has buried within it several provisions that relate to mental health parity and mandatory mental health and substance use disorder benefits. If upheld, 106 these provisions will extend mental health parity law and create a mandatory mental health and substance use disorder services requirement in a way that will benefit additional (but not all) groups of individuals with public and private health insurance.
The first ACA provision that is relevant to mental health parity law provides: "Section 2726 of the Public Health Service Act [PHSA] shall apply to qualified health plans in the same manner and to the same extent as such section applies to
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health insurance issuers and group health plans." 107 Section 2726 of the PHSA is the parallel citation to 42 U.S.C. § 300gg-26, the section within the United States Code where the non-ERISA provisions of MHPA as amended by MHPAEA are codified. 108 The dramatic effect of this provision is to expand the application of MHPA and MHPAEA from just large group health plans to all qualified health plans that are offered on one of the new ACA-created state or regional health insurance exchanges beginning on or after January 1, 2014. 109 The second relevant ACA provision makes conforming and technical changes to PHSA section 2726 to clarify the expansion of MHPA and MHPAEA to individual health insurance coverage.
110
As a result of these two provisions, many individual and small group health plans that were previously exempt from MHPA and MHPAEA now are prohibited from offering inferior mental health insurance benefits, including through higher deductibles, co-payments, and co-insurance rates, as well as lower inpatient day and outpatient visit limitations.
A third relevant ACA provision prevents group health plans and health insurance issuers offering group or individual health insurance coverage from establishing any lifetime as well as certain annual limits on the dollar value of essential health benefits for any participant or beneficiary.
111 Although ACA reserves the right of a group health plan or health insurance coverage to impose annual and lifetime per beneficiary limits on specific covered benefits that are not essential health benefits, 112 mental health and substance use disorder benefits, ) (making its provisions applicable to "group health plans or health insurance coverage offered in connection with such a plan"), with the newly amended 42 U.S.C. § 300gg-26 (2010) (making its provisions applicable to a "group health plan or a health insurance issuer offering group or individual health insurance"). 110 ACA § 1563(c)(4) (identifying the conforming and technical changes that will be made to former 42 U.S.C. § 300gg-5 (current 42 U.S.C. § 300gg-26)); Historical and Statutory Notes for former 42 U.S.C. § 300gg-5 (noting that former 42 U.S.C. § 300gg-5 was transferred to 42 U.S.C. § 300gg-26); see also EHB BULLETIN, supra note 23, at 12 ("The Affordable Care Act also specifically extends MHPAEA to the individual market."). 111 ACA § 10101 (adding new PHSA § 2711(a)). ACA prohibits lifetime dollar limits on essential benefits in any grandfathered or non-grandfathered health plan or insurance policy issued or renewed on or after September 23, 2010. Id. ACA restricts and phases out annual dollar limits that all grandfathered and non-grandfathered group health plans, as well as non-grandfathered individual health insurance plans issued after March 23, 2010, can place on essential benefits; that is, none of these plans can impose an annual dollar limit lower than: (i) $750,000 for a plan year or policy year starting on or after September 23, 2010, but before September 23, 2011; (ii) $1.25 million for a plan year or policy year starting on or after September 23, 2011, but before September 23, 2012; or (iii) $2 million for a plan year or policy year starting on or after September 23, 2012, but before January 1, 2014. 26 C.F.R. § 54.9815-2711T. ACA prohibits annual limits on essential benefits beginning January 1, 2014. See ACA § 10101 (adding new PHSA § 2711(a)(2)) ("With respect to plan years beginning prior to January 1, 2014, a group health plan and a health insurance issuer offering group or individual health insurance coverage may only establish a restricted annual limit on the dollar value of benefits for any participant or beneficiary with respect to the scope of benefits that are essential health and thus are excepted from the right of reservation. This third ACA provision builds on the original MHPA, which allowed lifetime and annual limits but only so long as such limits that applied to treatment of mental health conditions were not lower than those that applied to treatment of physical health conditions. 114 Now, ACA prohibits all lifetime as well as most annual limits. 115 Perhaps most importantly, a fourth set of ACA provisions mandates mental health and substance use disorder benefits in certain plan settings. Under section 1201 of ACA, a health insurance issuer that offers health insurance coverage in the individual or small group markets shall ensure that such coverage includes the EHB Package required by section 1302 of ACA.
116 Under section 1301 of ACA, qualified health plans that will be offered on the new ACA-created health insurance exchanges also must provide the EHB Package required by section 1302 of ACA.
117
Under section 1331 of ACA, the optional state basic health plans 118 also must provide the EHB Package required by section 1302 of ACA. 119 Finally, under section 2001 of ACA, Medicaid benchmark plans and benchmark-equivalent plans also must provide the EHB Package required by section 1302 of ACA. 120 Under the quadruple-referenced section 1302 of ACA, the EHB Package includes "mental health and substance use disorder services, including behavioral health treatment."
121
Read together, these four ACA provisions are significant. Federal law for the first time is mandating mental health and substance use disorder benefits in certain plan settings; that is, the non-exchange individual health plan, the non-exchange small group health plan, the exchange-offered qualified health plan, the state basic health plan, and the Medicaid benchmark and benchmark-equivalent plan settings.
122
Under regulations co-published by the Departments of Treasury, Labor, and HHS on June 17, 2010, the Departments clarified, however, that the essential health 113 ACA § 1302(b)(1)(E) (including mental health and substance use disorder services, including behavioral health treatment, within the definition of essential health benefits). 114 See supra Part III.A. 115 HEALTHCARE.GOV, supra note 111 ("The ban on lifetime dollar limits for most covered benefits applies to every health plan-whether you buy coverage for yourself or your family, or you receive coverage through your employer.").
116 ACA § 1201 (adding new PHSA § 2707(a), to be codified at 42 U.S.C. § 300gg-6(a)). 117 Id. § 1301(a)(1)(B) (adding new 42 U.S.C. § 18021(a)(1)(B)). 118 Individuals eligible for state basic health plan coverage include individuals who are not eligible for Medicaid and whose household income falls between 133 and 200 percent of the federal poverty level for the family involved as well as low-income legal resident immigrants. Id. § 1331(e). 119 Id. § 1331(a)(1) (requiring state basic health plans to provide "at least the essential health benefits described in section 1302(b) to eligible individuals in lieu of offering such individuals coverage through an Exchange"). 120 Id. , mental health and substance use disorder services will be part of the essential benefits package, a set of health care service categories that must be covered by certain plans, including all insurance policies that will be offered through the Exchanges, and Medicaid."). 122 See id.; see also EHB BULLETIN, supra note 24, at 1 (listing the health plan settings regulated by ACA's EHB requirement); CONSENSUS REPORT, supra note 17, at 7 box S-1, 18-23 (listing the health plan settings regulated by ACA's EHB requirement); Essential Health Benefits, HEALTHCARE.GOV, http://www.healthcare.gov/glossary/e/essential.html (last visited Mar. 1, 2012) ("Insurance policies must cover these [essential health] benefits in order to be certified and offered in Exchanges, and all Medicaid state plans must cover these services by 2014."). 715-1251(a), which defines "grandfathered health plan coverage" as "coverage provided by a group health plan, or a health insurance issuer, in which an individual was enrolled on March 23, 2010"). 125 Id. at 34541 (defining grandfathered plans and identifying the ways in which grandfathered plans can lose grandfathered status, turning them into non-grandfathered plans). 126 Id. (ii) any increase in a percentage cost-sharing requirement; (iii) certain increases in fixed-amount cost-sharing requirements, including deductibles and out-of-pocket limits but not co-payments; (iv) certain increases in fixed-amount co-payments; (v) certain decreases in contribution rates by employers and employee organizations; and (vi) certain changes in annual limits.
128
The Department of Treasury predicts that forty-nine to eighty percent of small employer plans and thirty-four to sixty-four percent of large employer plans will relinquish grandfathered status by the end of 2013.
129
Understanding the distinction between grandfathered and non-grandfathered plans is the key to understanding the application of ACA's health insurance reforms, including the EHB Provision. Grandfathered health plans are exempt from the vast majority of new insurance reforms required by ACA, 130 including newly added section 2707 of the Public Health Service Act, codified at 42 U.S.C. § 300gg-26, which requires health insurance issuers that offer health insurance coverage in the individual and small group markets to ensure that such coverage includes the EHB Package. 131 The result (in terms of mandated benefits) is that grandfathered health plans are regulated only by MHPA and MHPAEA, neither of which contains a mandated mental health or substance use disorder benefit, 132 as well as state law, which may or may not contain a mandated mental health and substance use disorder benefit.
133 Grandfathered health plans are not the only health plans that are exempt Among other requirements, ACA further specifies that the Secretary shall: (1) ensure that the scope of the EHB Package is equal to the scope of benefits provided under a typical employer plan; 138 (2) ensure that the EHB Package reflects an appropriate balance among the categories so that the benefits are not unduly weighted toward any category; 139 (3) not make coverage decisions, determine reimbursement rates, establish incentive programs, or design benefits in ways that discriminate against individuals because of their age, disability, or expected length of life; 140 (4) take into account the healthcare needs of diverse segments of the population, including women, children, persons with disabilities, and other groups; 141 and (5) periodically review the EHB Package and provide a report to Congress and the public assessing whether the EHB needs to be modified or updated.
142
Following ACA's enactment, HHS requested guidance from the IOM on the criteria and methods that should be used to determine and update the EHB Package. 143 To assist the Secretary with her responsibilities under ACA, the IOM formed the Committee. 144 The Committee was not charged with identifying the individual elements or the detailed provisions of the EHB Package; instead, the Committee was asked to develop a framework for considering an EHB Package that 134 CONSENSUS REPORT, supra note 17, at 18. 135 See id. at 18-20 (listing the health plan settings to which ACA's EHB requirement does not apply); Sara Rosenbaum, Joel Teitelbaum & Katherine Hayes, The Essential Health Benefits Provisions of the Affordable Care Act: Implications for People with Disabilities, 3 COMMONWEALTH FUND 1, 3 (2011) ("The act exempts large-group health plans, as well as self-insured ERISA plans and ERISA-governed multiemployer welfare arrangements not subject to state insurance law, from the essential benefit requirements."). 136 According to data on currently marketed health plans, thirty-four percent of individual or family health plan enrollees do not have coverage for substance abuse services and eighteen percent of enrollees do not have coverage for other mental health services. The Committee began its work by providing opportunities for the public to comment on the EHB Package through two different venues.
146 First, the Committee requested public comment on ten different Web-distributed questions relating to the EHB Package.
147 Second, the Committee invited a number of speakers to present their views regarding the EHB Package at public workshops held on January 13-14, 2011, in Washington, D.C., and on March 2, 2011, in Costa Mesa, California. 148 The invited speakers included experts from federal and state government, employers, insurers, healthcare providers, consumers, and healthcare researchers. 149 On August 29, 2011, the Committee released the Workshop Report, which summarized the speaker presentations from the D.C. and Costa Mesa workshops but did not contain the Committee's own recommendations regarding the EHB Package. 150 During the workshops, speaker discussion coalesced around several key topics including balancing the generosity of coverage with affordability, balancing specificity versus flexibility in terms of the EHB Package, evaluating existing state benefit mandates for inclusion into the EHB Package, and defining a typical employer plan.
151
Because many of the speaker comments-especially those relating to balancing the generosity of coverage with affordability and the desirability of specificity versus flexibility in terms of the EHB Package-are relevant to the analysis and proposal set forth in Part IV of this Article, relevant speaker comments are briefly summarized in Part IV.
On October 7, 2011, the Committee released the Consensus Report. 152 In the Consensus Report, the Committee concluded that the Secretary should begin simply by defining the EHB Package to reflect the scope and design of packages offered by small employers, modified to include the ten ACA-required EHB categories. 153 The Committee also identified criteria for the content of the aggregate EHB Package and specific components of the EHB Package, 154 as well as four policy foundations (or domains) that HHS should use in determining the EHB Package, including economics, ethics, population-based health, and evidence-based practice. 155 Like the speaker perspectives captured in the Workshop Report, perhaps the most important and recurring concern of the Committee that was expressed in the Consensus Report was the perceived tension between the need for comprehensive benefits and the concerns associated with the costs of such benefits. 156 145 Id. at 17. 146 Id. at 1-2. 147 Id. For the list of questions, see id. at 161-62. 148 Id. at 1-2. 149 Id. 150 Id. at 3. 151 Id. at 2. 152 CONSENSUS REPORT, supra note 17. 153 Id. at 1. 154 Id. 155 Id. 156 See id. at xi ("If the package of benefits . . . is too broad, insurance might become too expensive."); id. at 1 ("[T]he more expansive the benefit package is, the more it will likely cost and the less affordable it will be."); id. ("The basic tension [i]s how comprehensive the EHB could be and still be affordable for consumers and payers and sustainable as a program over time."); id. at 87 ("The central debate in constructing the EHB package has been balancing the comprehensiveness of benefits with their costs so as to promote value.").
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In the end, the Committee made five specific sets of recommendations. 157 The Committee's first major set of recommendations related to the establishment of the EHB Package. 158 That is, by May 1, 2012, the Secretary should establish an EHB Package guided by a national average premium target. 159 According to the Committee, the starting point in establishing the initial EHB Package should be the scope of benefits and design provided under a typical small employer plan in today's market. 160 To specify the initial EHB Package, the scope of benefits should then be modified to reflect the ten ACA-required benefit categories as well as additional criteria specified elsewhere in the Consensus Report for the content of both the aggregate EHB package and specific components of the EHB Package. 161 Importantly, the Committee recommended that section 1302(b)(1) of ACA, which states that "the essential health benefits . . . shall include at least the following general categories and the items and services covered within the categories," not be read to mean that every service that is within one of the ten ACA-required categories or is covered by a typical employer plan should automatically be included within the EHB Package. 162 Once the Secretary has developed a preliminary EHB Package, the Committee recommends that the package be further adjusted so that the expected national average premium for a silver plan with the EHB Package is actuarially equivalent to the average premium that would have been paid by small employers in 2014 for a comparable population with a typical benefit design. 163 The Committee finally recommended that the initial guidance provided by the Secretary on the contents of the EHB package should list standard benefit inclusions and exclusions at a level of specificity at least comparable to current best practice in the private and public insurance market. 164 The Committee's second major recommendation was that, by January 1, 2013, the Secretary should establish a framework for obtaining and analyzing data necessary for monitoring implementation of and updating the EHB Package.
165 157 For a discussion of the five recommendations, see id. at 90-149. 158 Id. at 90. 159 Id. 160 Id. 161 Id. For a list of the additional criteria relating to the content of the aggregate EHB package and specific components of the EHB package, see CONSENSUS REPORT, supra note 17, at 5 fig.S-2 . The Committee recommended that, in the aggregate, the EHB Package be affordable, maximize the number of people with insurance coverage, protect the most vulnerable by addressing the particular needs of those patients and populations, encourage better care practices by promoting the right care to the right patient in the right setting at the right time, advance stewardship of resources by focusing on high value services and reducing use of low value services (with value being defined as outcomes relative to costs), address the medical concerns of greatest importance to enrollees in EHB-related plans, as identified through a public deliberative process, and protect against the greatest financial risks due to catastrophic events or illnesses. See id. at 5. The Committee recommended that individual services, devices, and drugs that are part of the EHB Package be safe (i.e., expected benefits should be greater than expected harms), be medically effective and supported by a sufficient evidence base (or, in the absence of evidence on effectiveness, a credible standard of care), demonstrate meaningful improvement in outcomes over current effective services and treatments, be a medical service (and not primarily a social or educational service), and be cost effective (such that the health gain for individual and population health is sufficient to justify the additional cost to taxpayers and consumers). Id. 162 Id. at 63. 163 Id. at 90. 164 Id. 165 Id. at 117.
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According to the Committee, the framework should account for changes related to:
(1) providers (including payment rates, contracting mechanisms, financial incentives, and scope and organization of practice); (2) patients and consumers (including demographics, health status, disease burden, and problems with access); and (3) health plans (including characteristics of plans such as inclusions, exclusions, and limitations, cost-sharing practices, patterns of enrollment and disenrollment, network configuration, medical management programs, value-based insurance design, and types of external appeals, risk selection, solvency, impact of ACA-mandated limits on deductibles, co-payments, and out-of-pocket spending on the ability of plans to offer acceptable products).
166
The Committee's third major set of recommendations related to state innovation. As background, the health insurance reform provisions within ACA attempt to balance federal and state authority. 167 While federal law regulates certain aspects of the individual and small group markets through various pricing and issuance requirements, states are given relatively broad authority to operate their own exchanges and to regulate other aspects of health insurance. 168 Although ACA clearly states that the Secretary shall define the EHB Package, ACA does not address whether the Secretary is permitted to approve more than one EHB Package definition if the statutory requirements are otherwise satisfied. 169 Because the Committee believes that the Secretary has the authority to approve refinements of the EHB Package definition, if she chooses to do so, 170 the Committee's third major set of recommendations relate to the EHB Package in terms of state innovation. Specifically, for states administering their own exchanges that wish to adopt a variant of the Federal EHB Package, the Committee recommended that the Secretary should use statutory authority to grant such requests, provided that: (1) the statespecific EHB Package definition is consistent with the requirements of section 1302 of the ACA and the Committee's criteria relating to the aggregate and specific content of the EHB package; (2) the state definition produces a package that is actuarially equivalent to the national package established by the Secretary; and (3) each state's variance request is supported by a process that has included meaningful public input.
171
The Committee's fourth major set of recommendations related to updating the EHB Package. That is, the Secretary should, beginning in 2015 and annually thereafter, update the EHB Package with the goal of making the EHB Package more fully evidence-based, specific, and value-promoting. 172 The Committee also recommended that the Secretary explicitly incorporate costs into updates to the EHB Package and obtain an actuarial estimate of the national average premium for a silver-level plan with the existing EHB Package in the next year. 173 According to the Committee, the actuarial estimate should account for trends in medical prices, utilization, new technologies, and population characteristics. 174 Finally, any changes to the EHB Package should not exceed the actuarially estimated cost of the current 166 Id. 167 Id. 168 Id. 169 Id. 170 Id. 171 Id. at 131-32. 172 Id. at 9-10. 173 Id. at 10. 174 Id.
A PROPOSAL FOR COMPREHENSIVE AND SPECIFIC ESSENTIAL MENTAL HEALTH AND SUBSTANCE USE DISORDER BENEFITS 493
package in the next year. 175 To ensure over time that EHB-defined packages are affordable and offer reasonable coverage, the Committee also recommended that the Secretary, working in collaboration with others, develop a strategy for controlling rates of growth in healthcare spending across all sectors in line with the rate of growth in the economy.
176
The Committee's fifth major set of recommendations related to an NBAC. That is, the Secretary should establish an NBAC, staffed by HHS but appointed through a nonpartisan process, such as the Office of the Comptroller General of the United States. 177 The Committee recommended that the NBAC should: (1) by January 1, 2013, advise the Secretary on a research plan and data requirements for updating the EHB Package; (2) starting in 2015 for implementation in 2016, make recommendations annually to the Secretary regarding any changes to the EHB Package by applying the Committee's recommended criteria relating to the aggregate and individual content of the EHB Package, any changes to the premium target, and any mechanisms that would enhance the evidence base of the EHB Package and its potential for promoting value; and (3) advise the Secretary on conducting and using the results of a periodic national public deliberative process to inform its recommendations around updates to the EHB Package.
E. THE HHS ESSENTIAL HEALTH BENEFITS BULLETIN OF 2011
Following the release of the Consensus Report, HHS held an additional series of "listening sessions" with consumers, providers, employers, plans, state representatives, and other stakeholders in different cities across the United States.
179
During these sessions, some consumer and provider representatives expressed their concern regarding the Committee's emphasis in its Consensus Report on cost over comprehensiveness of benefits, the need for the Secretary to spell out specific, uniform benefits in regulations, and the fact that small group plans may not represent the typical employer plan envisioned by ACA. 180 On the other hand, some employer and health insurance representatives expressed their support for a more moderate benefit package, flexibility in the EHB Package across the country to reflect local preferences and practices, and benchmarking the EHB Package to small employer plans.
181
On December 16, 2011, HHS released its Essential Health Benefits Bulletin.
182
The EHB Bulletin provides information and solicits comments on a regulatory approach that HHS plans to propose to define the EHB Package. 183 More specifically, the EHB Bulletin outlines HHS's goal of pursuing an approach that will: (1) encompass the ten ACA-required categories of benefits; (2) reflect typical employer health benefit plans; (3) reflect balance among the ten ACA-required categories of benefits; (4) account for diverse health needs across many populations; (5) ensure that there are no incentives for coverage decisions, cost sharing, or 175 Id. 176 Id. at 10-11. 177 Id. at 11-12. 178 Id. 179 EHB BULLETIN, supra note 23, at 3. 180 See id. at 3. 181 See id. 182 Id. 183 Id. at 1.
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reimbursement rates to discriminate impermissibly against individuals because of their age, disability, or expected length of life; (6) ensure compliance with MHPAEA; (7) provide states a role in defining the EHB Package; and (8) balance comprehensiveness and affordability for those purchasing coverage.
184
Given the Committee's recommendations in its Consensus Report, including the Committee's recommendation that the Secretary's initial guidance should list standard benefit inclusions and exclusions at a level of specificity at least comparable to current best practice in the private and public insurance market, the content of the EHB Bulletin is surprising. In the EHB Bulletin, HHS explains its intent not to propose one comprehensive, specific benefit package for all health plans in the nation to follow. 185 Instead, HHS intends to leave the states broad discretion in defining the EHB Package by allowing each state to select a benchmark plan in that state. 186 The selected benchmark plan would serve as a reference plan, reflecting both the scope of services and any limits offered by a typical employer plan in that state. 187 According to statements made by the Secretary at a news conference, HHS's goal is to ensure that state leaders can tailor health insurance requirements to local conditions and priorities; that is, " [c] overage that works in Florida may not work in Nebraska."
188 HHS intends not only to allow health insurance issuers to adopt the scope of services and limits of the selected state benchmark, but also to vary the benchmarked benefits within certain parameters.
189
More specifically, HHS intends to propose that states select a single benchmark to serve as the standard for both exchange-offered qualified health plans in the state as well as non-exchange-offered individual and small group health plans in the state.
190 HHS believes that the following four benchmark plans, at least for the twoyear (2014-2015) transition period immediately following the compliance date for the EHB Provision, best reflect ACA's intent: (1) the largest plan by enrollment in any of the three largest small group insurance products in the state's small group market; (2) any of the largest three state employee health benefit plans by enrollment; (3) any of the largest three national Federal Employees Health Benefit Program (FEHBP) plan options by enrollment; or (4) the largest insured commercial non-Medicaid HMO operating in the state.
191 HHS intends to assess the benchmark process for year 2016 and beyond based on evaluation and feedback.
192
If a state does not exercise the option to select a benchmark health plan, HHS intends to propose that the default benchmark plan for the state will be the largest plan by enrollment in the largest product in the state's small group market. 193 In light of ACA's requirement that states defray the costs of state-mandated benefits in excess of the EHB Package for individuals enrolled in any qualified health plan 184 Id. at 8. 185 196 HHS intends to evaluate the benchmark approach for calendar year 2016 and develop an approach that may exclude some state benefit mandates from inclusion in the state EHB Package.
197
HHS recognizes that not every state-selected benchmark plan will cover all ten categories of ACA-required services. 198 For example, some selected benchmark plans may not include habilitative services, pediatric oral and vision services, or mental health and substance use disorder services (especially in light of MHPA and MHPAEA, neither of which contains a mandatory mental health or substance use disorder benefit).
199 HHS intends to propose that if a selected benchmark is missing an ACA-required benefit category, the benefit category must nevertheless be covered by health plans required to offer the EHB Package. 200 Stated another way, a state may need to supplement the benchmark plan to cover all ten of the ACArequired benefit categories.
201 HHS intends to propose that if a benchmark plan is missing one or more categories of required benefits, the state must supplement the missing categories using the benefits from any other benchmark option. 202 In a state with a default benchmark with missing categories, the benchmark plan would be supplemented using the largest plan in the benchmark type (e.g., small group plans or state employee plans of FEHBP) by enrollment offering the benefit. 203 If none of the benchmark options in that benchmark type offer the benefit, the benefit will be supplemented using the FEHBP plan with the largest enrollment.
204
HHS also intends to propose that mental health parity (i.e., MHPA as expanded by MHPAEA) applies in the context of health plans required to provide the EHB Package, consistent with ACA's statutory extension of federal mental health parity law to qualified health plans discussed in Part III.C, supra.
205
HHS further intends to propose that health plan benefits be "substantially equal" to the benefits of the benchmark plan selected by the state and modified as necessary 194 204 Id. For example, in a state where the default benchmark is in place but that default plan does not offer mental health and substance abuse disorder benefits, the benchmark would be supplemented using the mental health and substance use disorder benefits offered in the largest small group benchmark plan option with coverage for mental health and substance use disorder benefits. Id. If none of the three small group market benchmark options offer mental health and substance use disorder benefits, that category would be based on the largest plan offering mental health and substance use disorder benefits in FEHBP. Id. 205 Id. at 12.
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to reflect the ten ACA-required service categories. 206 More specifically, HHS intends to propose that insurers have some flexibility to adjust benefits, including both the specific services covered and any quantitative limits, provided that they continue to cover all ten of the ACA-required benefit categories. 207 According to HHS, permitting some flexibility will: (1) provide greater choice to consumers; (2) promote plan innovation through coverage and design options; and (3) ensure that plans providing the EHB Package offer a certain minimum level of benefits.
208 HHS also intends to consider permitting benefit substitutions within and across each of the ten ACA-required benefit categories. 209 Again, HHS's purpose in issuing the EHB Bulletin is to provide information regarding its current intentions with respect to regulations it plans to propose in the future. 210 The EHB Bulletin is not, then, a formal set of proposed regulations designed to satisfy the Federal Administrative Procedure Act's notice and comment rule-making process. Like proposed rules, however, HHS is welcoming public input regarding the EHB Bulletin and received comments through January 31, 2012.
211 As of this writing, HHS has yet to issue proposed or final regulations implementing the EHB Provision.
Following January 1, 2014, the compliance deadline for the EHB Provision, HHS estimates that 4.8 million Americans who purchase health insurance in the individual market will gain some substance abuse coverage at parity with medical and surgical benefits and that 2.3 million Americans who purchase health insurance in the same market will gain some mental health coverage at parity with medical and surgical benefits.
212 However, the extent to which specific mental health and substance use disorder benefits ultimately are required to be provided to a specific insured depends on whether HHS adopts its intended approach described in the EHB Bulletin in final regulations and, if so, the benchmark plan that is actually selected by (or defaulted to in) each state, 213 the extent to which insurers are permitted to adjust the benchmark benefits, and the extent to which HHS allows service substitutions within and across the ten ACA-required benefit categories. 214 If a state selects (or is defaulted to) a benchmark plan with modest mental health and substance use disorder benefits, many individuals with mental illness, including alcohol and drug addiction, may not have a federal legal right to insurance benefits that will cover all of the inpatient and outpatient services that are recommended for 206 Id. 207 Id. 208 Id. 209 Id. 210 See id. at 1. 211 Id. 212 ASPE ISSUE BRIEF, supra note 136, at 1. These numbers do not include estimates of the nonindividual (or small group) market enrollees whose coverage does not currently include mental health and substance use disorder benefits. Id. at 2 n.4. 213 See, e.g., CONSENSUS REPORT, supra note 17, at 62 (discussing variation among insurers with respect to certain categories of benefits, including mental health and substance use disorder benefits; noting that some services such as inpatient and outpatient substance abuse detoxification are less frequently covered); Kavita Patel, Essential Health Benefits: Policy Considerations, HEALTH AFF. BLOG (Dec. 28, 2011, 2:51 PM), http://healthaffairs.org/blog/2011/12/28/essential-health-benefitspolicy-considerations/ ("[B]oth ASPE researchers as well [as] private sector surveys have found a great deal of variation around benefits in behavioral health . . . ."). 214 See EHB BULLETIN, supra note 23, at 12 (discussing HHS's intent to allow health plans to offer benefits that are "substantially equal" to the benchmark benefits and the fact that HHS is considering permitting substitutions within and across the ten ACA-required benefit categories).
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their conditions. 215 On the other hand, if a state selects (or is defaulted to) a benchmark plan with comprehensive mental health and substance use disorder benefits, a greater number of individuals with mental illness in that state will have a federal legal right to insurance coverage of medically necessary evidence-based mental health treatments, unless HHS allows health plans in the state to substantially adjust away from the benchmarked mental health benefits or substitute benefits in one of the other nine ACA-required categories for the benchmarked mental health benefits.
IV. ANALYSIS AND PROPOSAL
This Part IV analyzes the initial steps taken by HHS to implement the EHB Provision, 216 with a focus on the potentially negative clinical implications for individuals with mental health and substance use disorders and the potentially negative cost implications for health plans. Thus far, HHS understandably has focused on the EHB Package as a whole with scant attention devoted to mental health and substance use disorder benefits. On page 5 of the EHB Bulletin, HHS briefly notes that not all plans and health insurance products cover mental health and substance use disorder services. 217 And, on page 12 of the EHB Bulletin, HHS briefly notes that mental health and substance use disorder services are part of the EHB Package and that ACA extends federal mental health parity law to the individual health plan setting and the exchange-offered qualified health plan setting. 218 Other than these two points, HHS has not focused on the particular issues surrounding mental health and substance use disorder benefits in publicly available documentation relating to its initial implementation of the EHB Package.
HHS's scant attention to mental health and substance use disorder benefits likely is due to the scant attention received by such benefits in the Committee's Workshop Report and Consensus Report. In the Workshop Report, the Committee explained that "time constraints prohibited the [C]ommittee from hearing testimony related to each of the[] [ten ACA-required] categories in detail." 219 Chapter 7 of the Workshop Report does highlight some testimony specifically relating to mental health and substance use disorder benefits, however. 220 Dr. Kenneth Wells of the David Geffen School of Medicine at UCLA, Dr. Kavita Patel of the Semel Institute for Neuroscience and Human Behavior at UCLA, and Mr. Paul Samuels of the Legal Action Center and the Coalition for Whole Health provided important testimony regarding the need for access to a range of evidence-based mental health and substance use disorder treatments, the fact that mental health treatments must recognize the chronic (not just acute) dimensions of mental illness, and the need for collaboration and integration of services across the mental health, substance use disorder, and physical health sectors. 221 Individually, Dr. Wells also briefly addressed the association between mental illness and physical illness (including the fact that individuals with mental illness have a higher prevalence of physical illness), 498 AMERICAN JOURNAL OF LAW & MEDICINE VOL. 38 NO. 2&3 2012 the role of mental illness in premature mortality and morbidity, and the cost effectiveness of mental health treatments when viewed in light of societal costs associated with mental illness. 222 Dr. Patel also briefly addressed the importance of covering community-based mental healthcare, including the services provided by lay community workers and social caseworkers, citing the efficacy of community-based mental healthcare as reported in the National Institute of Mental Health's Community Partners in Care study, which focused on the quality of mental healthcare provided to individuals with depression in Los Angeles 223 as well as the Mental Health Infrastructure and Training Project, which focused on the mental healthcare needs of individuals with depression and post-traumatic stress disorder in post-Katrina New Orleans. 224 Finally, Mr. Samuels briefly addressed the importance of treating mental illness in light of co-morbidity problems. 225 Mr. Samuels explained that twenty-five percent of hospital admissions are directly related to untreated mental illness and substance use disorders, and the failure of insurers to adequately cover mental illness "cost[s] a lot of money" because individuals with untreated mental illness frequently develop physical illnesses (including heart disease and liver failure) when their underlying mental illnesses are not addressed.
226
Mr. Samuels concluded by stating that, "[a]ddressing these unmet [mental health] needs 'will save lives and huge amounts of money.'" 227 Other than presenting these three brief pieces of testimony, the Workshop Report did not specifically focus on mental health and substance use disorder benefits.
The Consensus Report also focused little on mental health and substance use disorder benefits other than recognizing that not all health plans cover substance abuse detoxification services, 228 that mental health and substance abuse coverage in individual health plans has varied more than in small group health plans, with coverage criteria being more influenced by state mandates, 229 that mental health and substance use disorder services appear less likely to be covered in standard commercial subscriber contracts, 230 and that, in terms of defining the EHB Package, areas of particular complexity include mental health services. 231 This Part IV seeks to remedy the informational and research limitations in HHS's initial steps towards implementing the EHB Package. Perhaps the primary theme of the Workshop Report, the Consensus Report, and the EHB Bulletin with respect to all ten of the ACA-required benefit categories was the perceived tension between developing a comprehensive EHB Package and keeping healthcare costs down. 232 The Workshop Report presented many pieces of testimony that addressed the "clear tension between the desire to make the EHB [P]ackage as comprehensive as possible and the need to make the EHB [P]ackage affordable . . . ." 233 Dr. Louis Jacques, Director of the Coverage & Analysis Group at the Centers for Medicare & Medicaid Services, specifically addressed the "competing needs of generosity and affordability." 234 The Consensus Report also focused on comprehensiveness of benefits versus cost: "If the package of benefits is too narrow, health insurance might be meaningless; if it is too broad, insurance might become too expensive." 235 The EHB Bulletin also stated as one of HHS's mains goals "balancing comprehensiveness and affordability." 236 Part IV argues that the intense focus on the perceived relationship between the comprehensiveness of benefits and healthcare costs in the Workshop Report, Consensus Report, and EHB Bulletin might be misplaced in the context of mental health and substance use disorder benefits. More specifically, this Part IV urges HHS to consider the current empirical literature suggesting that, holding other nonmental health and substance use disorder benefits equal, the availability and use of medically necessary mental health and substance use disorder benefits by individuals with mental illnesses may actually lower the total (that is, the combined physical and mental) healthcare costs for those individuals, thus making the provision of comprehensive inpatient, outpatient, and other mental health and substance use disorder benefits by health plans an economically efficient long-term decision. 237 Stated another way, this Part IV urges HHS to consider the possibility of long-term total healthcare cost returns on initial mental health treatment investments as HHS implements the Mental Health Benefit Sub-Provision.
A. TRADITIONAL CONCERNS REGARDING THE RELATIONSHIP BETWEEN MENTAL HEALTH AND SUBSTANCE USE DISORDER BENEFITS AND HEALTHCARE COSTS 238
The belief that mandatory mental health and substance use disorder benefits and mental health parity will cause healthcare costs to rise is not new. 239 As background, health insurers historically have focused on the problems of moral hazard and adverse selection when justifying mental health benefit disparities. 240 In the context of mental healthcare, moral hazard refers to the concern that individuals who do not pay for 100% of the cost of their own mental healthcare will use more mental health services because they do not value these services at their full cost. 241 To control moral hazard in the context of mental healthcare, insurers traditionally have imposed lower inpatient day and outpatient visit maximums, as well as higher deductibles, co-payments, and co-insurance amounts, on mental healthcare. 242 Notwithstanding insurers' concerns regarding moral hazard in the context of mental healthcare, many of which may be linked to the three-decades-old RAND Health Insurance Experiment, 243 recent studies demonstrate that the demand for mental health services is less price elastic than the demand for physical health services and that the current demand for mental health services is less price elastic than the demand for mental health services was twenty-five to thirty years ago. 244 Recent studies also suggest that deductibles (in both the traditional indemnity 245 and managed care 246 settings) and co-insurance amounts (in the managed care setting) have no impact and very little impact, respectively, on the demand for mental healthcare. 247 Additional studies that analyze the impact of managed healthcare and behavioral health carve-out plans 248 on demand for mental healthcare suggest that the implementation of managed behavioral healthcare undermines the assumed demand response as an efficiency argument against parity. 249 As a result, economists now suggest that the imposition of higher deductibles, co-payments, and co-insurance amounts on mental healthcare may no longer be justified on efficiency grounds and that the traditional practice of unequal health insurance benefit sets may need to be revisited. 250 Traditionally, insurers also have been concerned with adverse selection; that is, the concern that in a healthcare market with voluntary insurance or multiple insurers, plans that offer generous mental health benefits will attract individuals with greater mental healthcare needs, leading to higher service usage and costs for those insurers. 251 Historically, many insurers have not offered mental health benefits as a way of controlling adverse selection. 252 Of course, the two pre-conditions to adverse selection (voluntary insurance and multiple insurers) have been at the heart of the 245 In a traditional indemnity health plan, patients are free to select their primary care providers, specialty care providers, and hospital and other institutional care providers. However, indemnity plan patients usually are subject to relatively high deductibles and co-insurance amounts. See How do Deductibles and Copays Work?, STAY SMART STAY HEALTHY, http://www.staysmartstayhealthy.com/ deductibles_and_copays (last visited Mar. 3, 2012) . 246 In a managed care plan, enrollees usually are assigned to a primary care provider who must pre-authorize access to a specialty healthcare provider. Managed care plan enrollees typically pay a small co-payment (e.g., ten, fifteen, or twenty-five dollars) for each visit to a primary care or specialty care provider instead of a high deductible combined with co-insurance. Coverage is usually limited to a small class of providers in a particular service area, unless the enrollee has an emergency medical condition. In the typical managed care plan, healthcare is rationed and healthcare costs are controlled by managers, not by high cost-sharing amounts imposed on enrollees. See, e.g., Leonard S. Goldstein, Genuine Managed Care in Psychiatry: A Proposed Practice Model, 11 GEN. HOSP. PSYCHIATRY 271, 271 (1989) (referencing several definitions of managed care; offering one definition of "genuine managed care [;] " that is, the attempt to improve, where possible, the system of care; and characterizing other definitions of managed care by their attempts to lower the cost of medical care through benefit barriers, access barriers, treatment restrictions, case management, and other interventions). 247 252 SURGEON GENERAL REPORT, supra note 37, at 420; see also Barry et al., Still Unequal, supra note 57, at 134 (discussing adverse selection in the context of mental healthcare; explaining that "adverse-selection incentives could play a role in explaining the endurance of benefit limits. While the advent of managed care has attenuated fears that coverage expansions would exacerbate cost control problems, benefit restrictions could be motivated by a health plan's desire to avoid enrollees with a propensity to avail themselves of mental health care."). 253 Although Congress elected not to proceed with a single-payer system, ACA requires most individuals to maintain minimum essential health insurance coverage 254 and requires exchange-offered qualified health plans, non-exchange-offered individual health plans, non-exchange-offered small health plans, Medicaid benchmark and benchmark-equivalent plans, and state basic healthcare plans to include the EHB Package in certain health plan settings, including mental health and substance use disorder benefits. 255 If upheld, 256 these two sets of ACA provisions will lessen insurers' risks relating to adverse selection beginning on the provisions' compliance date of January 1, 2014.
B. EMPIRICAL LITERATURE ADDRESSING THE RELATIONSHIP BETWEEN MENTAL HEALTH AND SUBSTANCE USE DISORDER BENEFITS AND HEALTHCARE COSTS
Perceived moral hazard and adverse selection concerns may continue to exist following January 1, 2014, however, because ACA does not currently require certain categories of health plans (including grandfathered health plans, large group health plans, and self-insured group health plans) to provide the EHB Package, including mental health and substance use disorder benefits. 258 This Article is based on concern that such exempted health insurers-as well as those health plans that have significant leeway in designing their benefit packages and substituting essential services within and across ACA-required benefit categories-will continue to impose mental health benefit limitations and will provide minimal mental health and substance use disorder benefits, respectively, without recognizing the negative clinical and related cost implications of their benefit limitations and without taking into account the role of managed care in minimizing moral hazard and other efficiency concerns. 259 To address these concerns, the current empirical literature regarding the relationship between mental health and substance use disorder benefits 253 2, 2010) (discussing several economic implications of mental health benefit restrictions and recognizing that the moral hazard problem can be controlled through managed behavioral healthcare); SURGEON GENERAL REPORT, supra note 37, at 420 (discussing the clinical implications of mental health benefit restrictions).
A PROPOSAL FOR COMPREHENSIVE AND SPECIFIC ESSENTIAL MENTAL HEALTH AND SUBSTANCE USE DISORDER BENEFITS 503
and healthcare costs is presented below. As discussed in more detail below, a number of studies suggest that mental health benefit limitations may be associated with a lack of access to mental healthcare and untreated mental illness. 260 Studies also suggest that untreated mental illness may increase total healthcare costs over and above the cost of treating the mental illness, perhaps because individuals who have a mental illness are more likely to have a physical illness 261 and because untreated mental illness can worsen the prognosis of, prolong the period of recovery from, and increase the risk of mortality associated with physical illness. 262 Finally, a number of studies suggest that treating mental illness may either decrease or not statistically significantly increase total healthcare costs, even taking into account the costs of the provided mental health treatment. 263 In the early 1990s, researchers affiliated with the Group Health Cooperative of Puget Sound ("GHC") desired to better understand the burden of depression on individual patients and society as a whole. 264 As background, the researchers believed that diagnosis and treatment of depression in individuals could yield a societal return on investment by lowering rates of unemployment and disability, but the researchers were also aware of the need to understand and control healthcare costs as part of any policy recommendation or initiative. 265 The researchers thus set out to investigate the relationship between untreated depression and total healthcare costs in 6257 GHC health maintenance organization (HMO) members who were eighteen years of age or older and were diagnosed with depression made during an outpatient visit between April 1, 1992, and December 31, 1992. 266 Using computerized visit-diagnosis data, pharmacy records, and cost-accounting data from GHC, the researchers compared overall healthcare costs for primary care patients with recognized depression and overall healthcare costs for age-and gender-matched patients without depression. 267 The researchers found that the patients diagnosed with depression had higher annual healthcare costs ($4246 versus $2371), and fifty to seventy-five percent higher costs for every category of care, including the primary care setting, all medical specialties, the medical inpatient setting, and the pharmacy 504 AMERICAN JOURNAL OF LAW & MEDICINE VOL. 38 NO. 2&3 2012 and laboratory settings. 268 The researchers concluded not only that the diagnosis of depression was associated with a twofold increase in use of health services 269 but also that the greater medical utilization exceeded the costs that would be associated with treating the depression. 270 As part of their conclusion, the researchers recommended that policy decisions regarding the scope of mental health benefits take into account the association between depression and total healthcare costs.
271
In 1997, researchers affiliated with GHC published the results of a second study designed "to examine whether depressive symptoms in older adults contribute to the increased cost of general medical services." 272 The researchers conducted a four-year (1989-1993) prospective study of 2558 older-than-sixty-five adults in GHC. 273 Through a mail survey and telephone interviews, the researchers measured each participant's depressive symptoms at baseline (1989), at two years (1991), and at four years (1993) . 274 The researchers then compared each patient's depressive symptoms to data obtained from GHC's cost accounting system relating to each patient's total healthcare costs. 275 The researchers found that in the cohort of older adults studied, depressive symptoms were common, persistent, and associated with a significant increase in the cost of general medical services. 276 More specifically, the researchers found that patients with significant depression at baseline had higher median costs ($2147) during the first year after baseline than patients without depression ($1461). 277 Patients with significant depressive symptoms at baseline also had higher median costs at year four ($15,423) than patients without depressive symptoms ($10,152). 278 The researchers also found that the increase in the cost of general medical services associated with depression was spread over all components of healthcare.
279 During the year following baseline, for example, patients with depression had a higher number of inpatient admissions, outpatient visits, laboratory tests, emergency department visits, prescriptions, ancillary visits, and optometry visits. 280 The researchers further found that the increase in the cost of general medical services was not accounted for by an increase in specialty mental healthcare, 281 and that even after adjusting for differences in age, sex, and severity of 268 Id. at 850-52. 269 Id. at 854 ("These data demonstrate markedly higher health care costs among HMO patients with recognized depression . . . . A twofold difference in total cost between those diagnosed as having depression and the comparison group was maintained over 12 months of observation, suggesting a chronic component to utilization differences."). 270 Id. at 855 ("In this 9-month sample of HMO primary patients with recognized depression, depression-related specialty mental health care and antidepressant drugs accounted for approximately $3.8 million, while greater use of general medical services accounted for $8.9 million over 1 year."). A PROPOSAL FOR COMPREHENSIVE AND SPECIFIC ESSENTIAL MENTAL HEALTH AND SUBSTANCE USE DISORDER BENEFITS 505 chronic medical illness, the increase in healthcare costs remained significant. 282 The researchers formally concluded that depressive symptoms in older adults are associated with a significant increase-roughly fifty percent-in the total cost of general medical services. 283 The researchers also suggested that mental health insurance benefit disparities might be short-sighted because they ultimately may increase total healthcare costs. 284 Similar findings have been shown in other healthcare delivery settings. In 2009, researchers affiliated with Massachusetts General Hospital and Massachusetts Institution of Technology published the results of a study designed to better understand the interaction between depression and the cost of non-mental healthcare in eleven chronic co-morbid diseases. 285 To that end, the researchers examined the insurance claims of 618,780 patients enrolled in self-insured, private healthcare plans based primarily in Texas, California, and across the eastern seaboard. 286 The researchers examined the insurance records, dating from September 1, 2004, to August 31, 2005, for total annual non-mental health costs in eleven different disease categories, including asthma, back pain, congestive heart failure, coronary artery disease, diabetes, epilepsy, headache, hypertension, intervertebral disc disease, obesity, and joint pain. 287 In each disease cohort, the researchers calculated median annual non-mental health cost for individuals with and without depression. 288 The researchers found that patients with depression had higher median per-patient annual non-mental health costs than patients without depression in all eleven diseases studied. 289 The per-patient difference in non-mental health costs between nondepressed and depressed patients ranged from $1570 in obesity to $15,240 in congestive heart failure. 290 The ratio of cost between non-depressed and depressed patients ranged from 1.5 in obesity to 2.9 in epilepsy. 291 The researchers also found that the median annual pharmaceutical costs for the depressed patients were consistently higher than the pharmaceutical costs for the non-depressed patients, with a difference ranging from $590 in obesity to $1410 in epilepsy. 292 Finally, the researchers found that "each of the 11 chronic co-morbid diseases was more prevalent in the depressed cohort than in the non-depressed cohort" (with the ratio of 282 Id. at 1618, 1620-21. 283 Id. at 1618, 1621. 284 Id. at 1622 ("Our findings on the costs of health services are important because by the year 2040, persons older than 65 years are projected to make up 21% of the population and consume almost half of the nation's health care resources. Medicare currently spends only about 3% of its resources on mental health care and continues to have a 50% [now 45%] copayment for most outpatient mental health services. These policies may shift the costs of mental health treatment to primary care, where the lack of recognition and adequate treatment of depression are well documented and where depression may manifest itself in higher general medical costs. If depression is indeed a significant contributor to total health care costs, such restrictions of access to mental health services may be shortsighted."(footnotes omitted)). 285 prevalence between non-depressed and depressed patients ranging from 1.4 in coronary artery disease and hypertension to 6.8 in obesity).
293
Given this data, the Massachusetts-based researchers formally concluded that, even when controlling for the number of chronic co-morbid diseases, depressed patients had significantly higher costs than non-depressed patients in a magnitude consistent across the eleven chronic co-morbid diseases. 294 The researchers suggested several potential reasons for their findings, including the possibility that depressed patients engage in self-neglect, including non-compliance with recommended healthcare. 295 By way of explanation, the researchers noted that other studies have shown that self-neglect in diabetes and heart disease patients is correlated with higher utilization of emergency room, outpatient, inpatient, and specialty services. 296 The researchers also identified as a possible cause the association between depression and "higher rates of harmful lifestyle factors such as smoking, overeating, and lack of physical activity," as well as more severe pathophysiology across all chronic disease categories. 297 Finally, the researchers raised the question, but were unable to answer, whether there may be metabolic factors associated with depression that exacerbate the pathophysiology of co-morbid diseases.
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Similar depression-to-cost findings also have been demonstrated in the public healthcare program setting. In 2009, researchers at the University of Washington, Columbia University, the National Institute of Mental Health, and Green Ribbon Health published their analysis of the healthcare claims of 14,902 Medicare beneficiaries who were enrolled in a pilot disease management program designed to investigate the association between depression and total healthcare costs as well as specific components of healthcare costs. 299 The majority of the Medicare beneficiaries studied had diabetes, many had congestive heart failure, and approximately twenty percent had both diabetes and congestive heart failure. 300 The researchers divided the beneficiaries into three mental health status groups: 2108 beneficiaries who had been diagnosed with depression, 1081 beneficiaries who had not been officially diagnosed with depression but who screened positive when given a questionnaire or who reported taking antidepressant medication, and 11,713 beneficiaries who did not have depression. 301 The researchers found that the beneficiaries diagnosed with depression incurred approximately $22,960 in total 293 Id. at 395. 294 coupled with management of care, implementation of parity in insurance benefits for behavioral health care can improve insurance protection without increasing total costs." 360 The study authors explained that their findings reflected little or no effect of mental health parity implementation on mental health services use and total spending.
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The FEHBP is not alone in its mental health parity and mental health and substance use disorder benefit implementation cost experiences. Reports indicate that states with mental health parity legislation and mandatory mental health and substance use disorder benefits have had similar experiences. By several reports, California, Maine, Maryland, Minnesota, North Carolina, Pennsylvania, Rhode Island, South Carolina, and Vermont implemented mental health parity and/or mental health and substance use disorder benefits and subsequently experienced either lower costs or extremely modest cost increases (e.g., nineteen cents per member per month in Vermont) in the first year of implementation. 362 Additional studies report that Maryland and North Carolina experienced decreased costs following the implementation of mental health parity and mental health and substance use disorder benefits when such parity coincided with the introduction of managed behavioral healthcare.
363
In summary, employers and insurers have offered a number of different reasons for their disparate physical and mental health insurance benefits or lack of mental health and substance use disorder benefits, including the argument that comprehensive mental health benefits will cause costs to rise. However, as discussed in this Part IV.B, the current health plan literature suggests that untreated mental illness may be associated with increases in total healthcare costs and that treatment of mental illness may be associated with decreases in total healthcare costs. In addition, the current mental health economics literature suggests that managed behavioral healthcare may significantly reduce-if not eliminate-the problem of moral hazard in the context of mental healthcare. 364 Finally, recent studies of cost data obtained from healthcare delivery settings in which mental health parity and mental health and substance use disorder benefits has been implemented suggest that mental health benefits may have (at most) negligibly increased or (more typically) decreased total healthcare delivery costs in those settings. 365 The current empirical literature thus may not support across-the-board concerns associated with the costs of comprehensive mental health and substance use disorder benefits. 360 Cross/Blue Shield reduced its insurance premiums by five to six percent after one year's experience under the state's comprehensive parity law . . . . In North Carolina, mental health expenses have decreased every year since comprehensive parity for state and local employees was passed in 1992. Mental health costs, as a percentage of total health benefits, have decreased from 6.4 percent in 1992 to 3.1 percent in 1998 . . . . Cost analyses of the parity law in Vermont, the most comprehensive parity law in the country, found that for one major health plan, costs increased by 19 cents per member per month, and actually decreased by 9 percent for the other major health plan in the state." (citation omitted)). 363 The primary theme of the Workshop Report, the Consensus Report, and the EHB Bulletin with respect to all ten of the ACA-required benefit categories was the perceived tension between the comprehensiveness of benefits and healthcare cost increases. 366 Likely as a result of the intense focus on this perceived tension, the HHS plan identified in the EHB Bulletin is timid with respect to the comprehensiveness and specificity of the EHB Package. 367 If HHS's current plan is adopted, states will have broad discretion in defining the EHB Package (including, perhaps, a Package that contains modest mental health and substance use disorder benefits), health plans will have flexibility in adjusting benchmarked benefits (including adjustments that could further reduce mental health and substance use disorder benefits), and health plans may be permitted to substitute services within and across benefit categories (including substitutions away from mental health and substance use disorder services and toward services in one or more of the other nine ACA-required benefit categories).
368
This Part IV has shown that the intense focus on the perceived relationship between the comprehensiveness of benefits and healthcare cost increases in the Workshop Report, Consensus Report, and EHB Bulletin might be misplaced in the context of mental health and substance use disorder benefits. This Article thus proposes that HHS consider adopting a comprehensive essential mental health and substance use disorder benefit that includes, at a minimum, medically necessary and evidence-based inpatient and outpatient mental healthcare services, inpatient substance abuse detoxification services, inpatient and outpatient substance abuse rehabilitation services, emergency mental healthcare services, prescription drugs for mental health conditions, psychiatric disease management participation, and community-based mental healthcare services. The current literature suggests that the provision of these services to mentally ill individuals who need them may, in the long run, decrease or not increase total healthcare expenditures.
One question that remains is how specific the EHB Package should be in terms of the required mental health and substance use services. For example, should regulations implementing the EHB Package specifically list the health conditions or medical or other criteria for which particular mental health treatments, such as individual psychotherapy, group counseling, particular name brand or generic psychiatric drugs, electroconvulsive therapy, deep brain stimulation, or inpatient detoxification and rehabilitation services, will be covered? As background, the "specific v. flexible" debate in healthcare reform is a perennial issue. The Clinton administration's failed but incredibly specific Health Security Act of 1993 contained a sixty-one-page enumerated list of covered benefits. 369 Both the FEHBP and the Massachusetts Health Care Reform Law, on the other hand, contain broadly defined benefit categories. 370 The value of specificity versus flexibility continues to be debated, including in the statements made by speakers at the IOM workshops. On behalf of the American Congress of Obstetricians and Gynecologists, for example, 366 See supra notes 156, 232-36 and accompanying text. 367 EHB BULLETIN, supra note 23. 368 See id. at 12. 369 WORKSHOP REPORT, supra note 10, at 22; see Health Security Act of 1993, H.R. 3600, 103d Cong.
370 WORKSHOP REPORT, supra note 10, at 20.
